Cancer News and Research

Latest Cancer News and Research

Top-line final data from Provectus’ PV-10 phase 2 trial on metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that top-line final data from its phase 2 clinical trial of PV-10 for metastatic melanoma were presented at the 2nd European Post-Chicago Melanoma Meeting 2012, Interdisciplinary Global Conference on Developing New Treatments for Melanoma, on June 22, 2012, in Munich, Germany.

27 Jun 2012

Study: Moderate coffee intake reduces risk of heart failure

While current American Heart Association heart failure prevention guidelines warn against habitual coffee consumption, some studies propose a protective benefit, and still others find no association at all. Amidst this conflicting information, research from Beth Israel Deaconess Medical Center attempts to shift the conversation from a definitive yes or no, to a question of how much.

27 Jun 2012

Prenatal exposure to BPA appears to program uterine estrogen responsiveness in adulthood

Prenatal exposure to bisphenol A, or BPA, a chemical found in many common plastic household items, can cause numerous genes in the uterus to respond differently to estrogen in adulthood, according to a study using a mouse model. The results will be presented Tuesday at The Endocrine Society's 94th Annual Meeting in Houston.

27 Jun 2012

Seahorse Bioscience launches XF Palmitate-BSA FAO Reagent for FAO assays

Seahorse Bioscience, the world leader in manufacturing instrumentation and assay kits for measuring cellular metabolism, has announced the launch of its newest product, the XF Palmitate-BSA FAO Reagent, eliminating the need for radioactivity in fatty acid oxidation (FAO) assays.

27 Jun 2012

Sunshine Biopharma completes Adva-27a cytotoxicity study on multidrug-resistant lung cancer

Sunshine Biopharma Inc., a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed a cytotoxicity study of its lead compound, Adva-27a, in H69AR, a Multidrug Resistant Small Cell Lung Cancer cell line. Cytotoxicity studies measure the ability of a drug to destroy cancer cells in vitro.

27 Jun 2012

Link between bacterial vaginosis and female-to-male HIV transmission risk

An investigation led by UCSF has found that the risk of female-to-male HIV transmission is increased three fold for women with bacterial vaginosis, a common disorder in which the normal balance of bacteria in the vagina is disrupted.

27 Jun 2012

Caltech researchers develop technique to focus light inside biological tissue

Imagine if doctors could perform surgery without ever having to cut through your skin. Or if they could diagnose cancer by seeing tumors inside the body with a procedure that is as simple as an ultrasound.

27 Jun 2012

Astellas submits enzalutamide MAA with EMA for treatment of CRPC

Today, Astellas Pharma Inc. announces the submission of a European marketing authorisation application to the European Medicines Agency (EMA) for enzalutamide for the treatment of men with metastatic castration-resistant prostate cancer who have been previously treated with docetaxel-based chemotherapy.

27 Jun 2012

New FIRS data reveals lack of understanding and concern among public about lung disease

New data released by the Forum of International Respiratory Societies (FIRS) to coincide with World Spirometry Day today has revealed a lack of understanding and concern among the public about the world's biggest killer - lung disease, which now claims the lives of almost 4 million people a year.

27 Jun 2012

MRI scans determine whether chemotherapy is working long before tumors shrink

Studies on some 55 U.S. men and women with potentially deadly liver or pancreatic cancers show that specialized MRI scans can tell within a month whether highly toxic chemotherapy is working and killing tumor cells long before tumors actually shrink – or fail to shrink.

26 Jun 2012

Report on the global market for breast cancer diagnostics and drug technologies

Breast Cancer Diagnostic and Drug market are recovering after significant slowdown during the global recession. Having accurate market data and analysis will be essential to companies seeking to compete on the global stage as the market reemerges into success.

26 Jun 2012

New tissue-culture study: Fungicide can induce insulin resistance

A fungicide used on farm crops can induce insulin resistance, a new tissue-culture study finds, providing another piece of evidence linking environmental pollutants to diabetes. The results will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston.

26 Jun 2012

SCRI receives NIH grant for Science Adventure Lab program

Over the past three years, more than 20,000 students at 135 schools in Washington State have participated in the Science Adventure Lab program, an initiative launched by Seattle Children's Research Institute in 2009.

26 Jun 2012

Metformin reduces overall cancer risk in patients with Type 2 diabetes

A commonly prescribed diabetes drug, metformin, reduces the overall cancer risk in people with Type 2 diabetes, a large systematic review study finds. The results will be presented Monday at The Endocrine Society's 94th Annual Meeting in Houston.

26 Jun 2012

Reproductive hormone helps regulate food intake, energy metabolism without adverse effects

A reproductive hormone helps regulate food intake and energy metabolism without causing adverse effects, a new animal study finds. The results will be presented Monday at The Endocrine Society's 94th Annual Meeting in Houston.

26 Jun 2012

Nanoparticles that can slip through mucus barriers shown to protect against herpes infections

Johns Hopkins researchers say they have demonstrated, for the first time in animals, that nanoparticles can slip through mucus to deliver drugs directly to tissue surfaces in need of protection. The researchers used these mucus-penetrating particles (MPPs) to protect against vaginal herpes infections in mice and the goal is to create similar MPPs to deliver drugs that protect humans against sexually transmitted diseases or even treat cancer.

26 Jun 2012

Having antibodies for cutaneous HPV and sun exposure can act synergistically in BCC, SCC

Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and the German Cancer Research Center in Heidelberg have found that having antibodies for cutaneous types of human papillomavirus (HPV), coupled with sun exposure (ultraviolet radiation) or poor tanning ability, can act "synergistically" in the development of non-melanoma skin cancers such as basal cell carcinoma (BCC) and squamous cell carcinoma (SCC).

26 Jun 2012

Tiniest and heaviest fetuses at increased risk of being stillborn

The tiniest and the heaviest fetuses are at much higher risk of being stillborn than those of average weight, new research has found.

26 Jun 2012

New drug better than chemotherapy for skin cancer patients

A new drug, dabrafenib, shows improvements over chemotherapy for patients suffering from a form of advanced skin cancer, according to the results of a Phase III study (“BREAK-3” trial) published Online First in the Lancet.

26 Jun 2012

Cancer survivors benefit from healthy lifestyle

Australia’s first community-based Cancer Survivors Centre, which is based at the University of New South Wales, has joined the Dry July campaign in a bid to pinpoint the vital role a healthy lifestyle plays in fending off cancer and the after-effects of the disease.

26 Jun 2012

Cancer News and Research

Latest Cancer News and Research

Top-line final data from Provectus’ PV-10 phase 2 trial on metastatic melanoma

Study: Moderate coffee intake reduces risk of heart failure

Prenatal exposure to BPA appears to program uterine estrogen responsiveness in adulthood

Seahorse Bioscience launches XF Palmitate-BSA FAO Reagent for FAO assays

Sunshine Biopharma completes Adva-27a cytotoxicity study on multidrug-resistant lung cancer

Link between bacterial vaginosis and female-to-male HIV transmission risk

Caltech researchers develop technique to focus light inside biological tissue

Astellas submits enzalutamide MAA with EMA for treatment of CRPC

New FIRS data reveals lack of understanding and concern among public about lung disease

MRI scans determine whether chemotherapy is working long before tumors shrink

Report on the global market for breast cancer diagnostics and drug technologies

New tissue-culture study: Fungicide can induce insulin resistance

SCRI receives NIH grant for Science Adventure Lab program

Metformin reduces overall cancer risk in patients with Type 2 diabetes

Reproductive hormone helps regulate food intake, energy metabolism without adverse effects

Nanoparticles that can slip through mucus barriers shown to protect against herpes infections

Having antibodies for cutaneous HPV and sun exposure can act synergistically in BCC, SCC

Tiniest and heaviest fetuses at increased risk of being stillborn

New drug better than chemotherapy for skin cancer patients

Cancer survivors benefit from healthy lifestyle

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in